mevalonic acid has been researched along with Leukemia, Myeloid, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Ding, L; Fang, Z; Li, G; Li, Y; Lu, Z; Xu, B; Yao, J; Yu, L | 1 |
| Kalkat, M; Lang, KS; Li, Z; Minden, MD; Mullen, PJ; Pandyra, A; Penn, LZ; Pong, JT; Schimmer, AD; Trudel, S; Yu, R | 1 |
| Burke, LP; Kukoly, CA | 1 |
3 other study(ies) available for mevalonic acid and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways.
Topics: Animals; Apoptosis; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Mevalonic Acid; Mice; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors; Signal Transduction; Simvastatin | 2023 |
Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Dipyridamole; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA Synthase; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Male; Mevalonic Acid; Mice; Multiple Myeloma; Sterol Regulatory Element Binding Protein 2 | 2014 |
Statins induce lethal effects in acute myeloblastic leukemia [corrected] cells within 72 hours.
Topics: Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukemia, Myeloid, Acute; Lovastatin; Mevalonic Acid | 2008 |